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Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular carcinoma (HCC) that can deteriorate liver function. The long-term deterioration of liver function after TACE can originate from the progression of energy malnutrition (Saito et al. [@CR1_43]). In general, the non-protein respiratory quotient (npRQ) is the main factor used to evaluate energy metabolism on the basis of indirect calorimetry (Tajika et al. [@CR2_43]). Short-term reduction in npRQ was found to be related to long-term liver dysfunction after TACE (Saito et al. [@CR1_43]). On the other hand, no background characteristic factors that could promote the development of energy malnutrition after TACE have been identified. We aimed to clarify the background factors related to npRQ reduction after TACE.

We performed a prospective cohort study on a total of 100 patients (mean age: 70.9 years, range: 41-87 years; male:female ratio: 61:39) who underwent TACE for HCC. All patients were Japanese and had liver cirrhosis. Overall, 58 patients were classified into Child's grade A and 42 were classified into grade B. The etiology of cirrhosis was as follows: hepatitis B in 12 patients, hepatitis C in 71, alcoholic liver dysfunction in 28, primary biliary cirrhosis in 2, autoimmune hepatitis in 2, non-alcoholic fatty liver disease in 5, and unknown in 1, although each category overlaps with others. Blood biochemical examinations were performed before TACE and indirect calorimetry was performed before and 7 days after TACE. The therapeutic volume was calculated from the distribution of Lipiodol deposits on a liver CT scan after TACE. The relationship between two variables was investigated by Spearman's correlation coefficient test. Logarithmic transformation was performed only when variables displayed skewed distributions.

Spearman's correlation coefficient test showed that npRQ ratio (Day 7/Day 0) was significantly related to des-γ-carboxy prothrombin (DCP) (Day 0) (Figure [1](#Fig1){ref-type="fig"}: p=0.0481, r=-0.2033). The npRQ ratio was not related to any other blood biochemical factors (Day 0) (platelets, lymphocytes, aspartate aminotransferase, alanine aminotransferase, γ-glutamyltranspeptidase, total bilirubin, cholinesterase, albumin, prealbumin, branched-chain amino acid/tyrosine ratio, C-reactive protein, glucose, insulin, HOMA-IR, hemoglobin A1c, indocyanine green test retention rate at 15 min, type 4 collagen 7S, hyaluronic acid, and alpha fetoprotein) or the therapeutic volume (p\>0.05). In addition, the npRQ ratio was not also related to alpha fetoprotein (Day 0) (p=0.6254, r=-0.0494).Figure 1**The correlation between non-protein respiratory quotient (npRQ) ratio (Day 7/Day 0) and des-γ-carboxy prothrombin (DCP) (Day 0) in hepatocellular carcinoma (HCC) patients undergoing transcatheter arterial chemoembolization (TACE).** The npRQ ratio (Day 7/Day 0) was significantly related to des-γ-carboxy prothrombin (DCP) (Day 0) in HCC patients undergoing TACE by Pearson's correlation coefficient test (p=0.0481, r=-0.2033).

In general, DCP is an HCC tumor marker (Liebman et al. [@CR3_43]). In this study, DCP was significantly related to the TNM stage and BCLC stage of HCC (p=0.0072 and 0.0001, respectively). On the other hand, DCP production is stimulated by hypoxia in human samples (Murata et al. [@CR4_43]). Liver cirrhosis is associated with a state of hypoxia (Le Couteur et al. [@CR5_43]). In liver cirrhosis, the increased resistance to blood flow and oxygen delivery due to an organized basement membrane results in hypoxia (Le Couteur et al. [@CR5_43]). A recent study showed that serum DCP level was raised in cirrhotic patients without HCC, especially among liver transplant candidates (Yamashiki et al. [@CR6_43]). Our previous study also showed that HCC patients against a background of liver cirrhosis with a high level of DCP before TACE would become sensitive to hypoxia, and that the tolerability for hypoxia of non-tumoral liver after TACE would decrease (Saito et al. [@CR7_43]). In addition, a previous study showed that the severe hypoxic state in the liver parenchyma would influence the decrease of npRQ (Mimura & Furuya [@CR8_43]). In this study, npRQ reduction after TACE was not affected by the treated size of HCC (p\>0.05). It was suggested that cancer cells did not play any positively supportive roles of energy metabolism. Therefore, it was suggested that the HCC patients against a background of cirrhosis with a severe hypoxic state would easily develop npRQ reduction after TACE.

In conclusion, npRQ reduction after TACE was related to a high value of DCP before TACE. The energy malnutrition after TACE would originate from low tolerability for hypoxia of non-tumoral liver. The HCC patients with a high value of DCP before TACE would clinically have a high risk of the energy malnutrition after TACE.
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